Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2000 2
2001 1
2010 1
2011 3
2013 1
2014 1
2015 1
2016 1
2018 1
2019 2
2021 2
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.
Byrd JC, Hillmen P, Ghia P, Kater AP, Chanan-Khan A, Furman RR, O'Brien S, Yenerel MN, Illés A, Kay N, Garcia-Marco JA, Mato A, Pinilla-Ibarz J, Seymour JF, Lepretre S, Stilgenbauer S, Robak T, Rothbaum W, Izumi R, Hamdy A, Patel P, Higgins K, Sohoni S, Jurczak W. Byrd JC, et al. Among authors: sohoni s. J Clin Oncol. 2021 Nov 1;39(31):3441-3452. doi: 10.1200/JCO.21.01210. Epub 2021 Jul 26. J Clin Oncol. 2021. PMID: 34310172 Free PMC article. Clinical Trial.
All-grade atrial fibrillation/atrial flutter incidence was significantly lower with acalabrutinib versus ibrutinib (9.4% v 16.0%; P = .02); among other selected secondary end points, grade 3 or higher infections (30.8% v 30.0%) and Richter transformations (3.8% v 4.9%) wer …
All-grade atrial fibrillation/atrial flutter incidence was significantly lower with acalabrutinib versus ibrutinib (9.4% v 16.0%; P = …
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
Dickinson MJ, Barba P, Jäger U, Shah NN, Blaise D, Briones J, Shune L, Boissel N, Bondanza A, Mariconti L, Marchal AL, Quinn DS, Yang J, Price A, Sohoni A, Treanor LM, Orlando EJ, Mataraza J, Davis J, Lu D, Zhu X, Engels B, Moutouh-de Parseval L, Brogdon JL, Moschetta M, Flinn IW. Dickinson MJ, et al. Among authors: sohoni a. Cancer Discov. 2023 Sep 6;13(9):1982-1997. doi: 10.1158/2159-8290.CD-22-1276. Cancer Discov. 2023. PMID: 37249512 Free PMC article.
YTB323, which expresses the same validated CAR as tisagenlecleucel, can be manufactured in <2 days while retaining T-cell stemness and enhancing clinical activity at a 25-fold lower dose. See related commentary by Wang, p. 1961. This article is featured in Selected Arti …
YTB323, which expresses the same validated CAR as tisagenlecleucel, can be manufactured in <2 days while retaining T-cell stemness and en …
Long-term exposure to ambient PM2·5, active commuting, and farming activity and cardiovascular disease risk in adults in China: a prospective cohort study.
Sun D, Liu C, Ding Y, Yu C, Guo Y, Sun D, Pang Y, Pei P, Du H, Yang L, Chen Y, Meng X, Liu Y, Liu J, Sohoni R, Sansome G, Chen J, Chen Z, Lv J, Kan H, Li L; China Kadoorie Biobank Collaborative Group. Sun D, et al. Among authors: sohoni r. Lancet Planet Health. 2023 Apr;7(4):e304-e312. doi: 10.1016/S2542-5196(23)00047-5. Lancet Planet Health. 2023. PMID: 37019571 Free PMC article.
The above associations differed significantly between PM(2.5) strata (all interaction p values <0.0001). INTERPRETATION: For participants with long-term exposure to higher ambient PM(2.5) concentrations, the cardiovascular benefits of active commuting and farming activi …
The above associations differed significantly between PM(2.5) strata (all interaction p values <0.0001). INTERPRETATION: For parti …
Several environmental oestrogens are also anti-androgens.
Sohoni P, Sumpter JP. Sohoni P, et al. J Endocrinol. 1998 Sep;158(3):327-39. doi: 10.1677/joe.0.1580327. J Endocrinol. 1998. PMID: 9846162
The previously reported anti-androgenic activities of vinclozolin and p,p'-1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE) were confirmed. We also found that o,p'-1,1,1,-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT), bisphenol A and butyl be …
The previously reported anti-androgenic activities of vinclozolin and p,p'-1,1-dichloro-2,2-bis(p-chlorophenyl) ethylen …
2D Nano-Sonosensitizers Facilitate Energy Transfer to Enhance Sonodynamic Therapy.
Lin G, Nash GT, Luo T, Ghosh I, Sohoni S, Christofferson AJ, Liu G, Engel GS, Lin W. Lin G, et al. Among authors: sohoni s. Adv Mater. 2023 May;35(19):e2212069. doi: 10.1002/adma.202212069. Epub 2023 Mar 26. Adv Mater. 2023. PMID: 36840977 Free PMC article.
Composed of Hf-oxo secondary building units (SBUs) and iridium-based linkers, the MOL is anchored with 5,10,15,20-tetra(p-benzoato)porphyrin (TBP) sensitizers on the SBUs to afford TBP@MOL. TBP@MOL shows 14.1- and 7.4-fold higher singlet oxygen ((1) O(2) ) generation than …
Composed of Hf-oxo secondary building units (SBUs) and iridium-based linkers, the MOL is anchored with 5,10,15,20-tetra(p-benzoato)po …
Efficacy of two commercially available dentifrices in reducing dentinal hypersensitivity.
Prasad KV, Sohoni R, Tikare S, Yalamalli M, Rajesh G, Javali SB. Prasad KV, et al. Among authors: sohoni r. Indian J Dent Res. 2010 Apr-Jun;21(2):224-30. doi: 10.4103/0970-9290.66639. Indian J Dent Res. 2010. PMID: 20657092 Free article. Clinical Trial.

The 12th-week scores as compared to baseline scores for tactile, heat and cold tests in the test group showed a reduction in tooth hypersensitivity by 36.67% (P < 0.01), 20.35% (P < 0.01) and 53.64 % (P < 0.01), respectively, in the first set of teet

…
The 12th-week scores as compared to baseline scores for tactile, heat and cold tests in the test group showed a reduction in tooth hypersens …
26 results